Story · Public Health
Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes
1 outlet · first reported by WSJ Health on
The biopharmaceutical company said it now expects total revenue growth of 15% to 25% for the year, compared with a previous outlook for up to 10% growth. (WSJ Health)
Coverage, in order
-
Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes
The biopharmaceutical company said it now expects total revenue growth of 15% to 25% for the year, compared with a previous outlook for up to 10% growth.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.